Nausea: What Could Be Causing It

How the Body Generates Nausea

Nausea is not a disease. It is a signal, generated by a network of neural pathways that converge on the brainstem's nucleus tractus solitarius (NTS) and the chemoreceptor trigger zone (CTZ) in the area postrema. Vagal afferents from the gut, vestibular input from the inner ear, and cortical signals from higher brain centers all feed into this system [1].

The CTZ sits outside the blood-brain barrier, which means circulating toxins, drugs, and metabolic byproducts can activate it directly. This explains why uremia, hyperglycemia, and chemotherapy drugs all produce nausea through a shared mechanism: bloodborne stimulation of dopamine D2 and serotonin 5-HT3 receptors in the area postrema [1]. Peripheral triggers, by contrast, travel through the vagus nerve. Gastric distension, mucosal inflammation, and slowed motility each activate mechanoreceptors and chemoreceptors in the gut wall that relay signals upward to the NTS.

The American Gastroenterological Association's 2001 technical review on nausea and vomiting describes the vomiting center not as a single anatomical structure but as a "central pattern generator" distributed across the medulla [2]. This distributed architecture is why so many different conditions produce the same symptom. A migraine, a kidney stone, and a plate of spoiled shellfish can all make you feel identically nauseated despite having nothing else in common.

Gastrointestinal Causes

GI disorders account for the largest share of nausea complaints in primary care. The answer is usually one of a handful of conditions, though overlap is common.

Gastroparesis delays gastric emptying without mechanical obstruction. Diabetic gastroparesis is the most studied form. A gastric emptying scintigraphy study retaining more than 10% of a radiolabeled meal at 4 hours confirms the diagnosis [3]. Symptoms include early satiety, bloating, and postprandial nausea that worsens with solid food. The condition affects roughly 5% of type 1 and 1% of type 2 diabetes patients over a 10-year period, according to Olmsted County epidemiological data [3].

Functional dyspepsia produces nausea without structural abnormality. Rome IV criteria require bothersome postprandial fullness, early satiation, or epigastric pain for at least 3 months with symptom onset at least 6 months before diagnosis [4]. A 2015 meta-analysis in Gut estimated global functional dyspepsia prevalence at 7.6% using Rome III criteria [4].

Peptic ulcer disease and GERD produce nausea alongside burning epigastric pain or heartburn, respectively. H. pylori testing and a trial of proton pump inhibitors are standard first steps. Small bowel obstruction causes nausea with colicky pain, distension, and obstipation. That pattern demands urgent imaging.

Acute gastroenteritis remains the single most common cause of sudden-onset nausea worldwide. Norovirus alone causes an estimated 685 million cases annually, per CDC data [5]. The presentation is usually self-limited, resolving within 24 to 72 hours with supportive care.

Medication-Induced Nausea

Drugs are the second most common cause of nausea, and the list of offending agents is long. The mechanism varies by drug class: direct CTZ activation, gastroparesis induction, mucosal irritation, or serotonin-pathway modulation.

Opioids trigger nausea in 25-40% of patients through mu-receptor activation in the CTZ and delayed gastric emptying [6]. NSAIDs irritate gastric mucosa. SSRIs increase serotonin availability in the gut (where 95% of the body's serotonin resides), producing nausea that typically peaks during the first 1 to 2 weeks and then attenuates.

GLP-1 receptor agonists deserve special attention given their rapid adoption for weight management and type 2 diabetes. In the STEP-1 trial (N=1,961), 44.2% of participants on semaglutide 2.4 mg reported nausea compared with 17.8% in the placebo group [7]. The mechanism involves both central 5-HT3 receptor activation and slowed gastric emptying. Dose titration over 16 to 20 weeks reduces incidence and severity. Only 4.5% of semaglutide-treated participants discontinued due to GI adverse events in STEP-1 [7].

Tirzepatide follows a similar pattern. In the SURMOUNT-1 trial (N=2,539), nausea occurred in 24.6% of the 5 mg group, 33.3% at 10 mg, and 31.0% at 15 mg, versus 9.5% with placebo [8]. Most episodes were mild to moderate and concentrated during dose-escalation phases.

Antibiotics, particularly macrolides (erythromycin, azithromycin) and metronidazole, are frequent culprits. Erythromycin acts as a motilin agonist, which paradoxically makes it both a cause of nausea and, at low doses, a prokinetic treatment for gastroparesis.

A careful medication reconciliation should be the first diagnostic step for any patient with new-onset nausea. This is especially true in older adults on polypharmacy regimens, where drug interactions compound individual side-effect profiles.

Hormonal and Metabolic Triggers

Hormonal fluctuations are a potent nausea trigger, and the archetype is pregnancy. Nausea and vomiting of pregnancy (NVP) affects 70-80% of pregnant individuals, typically between weeks 6 and 16 [9]. The severity spectrum ranges from mild morning sickness to hyperemesis gravidarum, which complicates roughly 0.3-3% of pregnancies and requires IV fluid resuscitation.

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 189 recommends pyridoxine (vitamin B6) 10-25 mg three times daily as first-line therapy for NVP, with the addition of doxylamine if symptoms persist [9]. The combination of doxylamine-pyridoxine (Diclegis/Bonjesta) is the only FDA-approved treatment for NVP.

Diabetic ketoacidosis (DKA) produces nausea through direct CTZ stimulation by ketone bodies and metabolic acidosis. Nausea is present in roughly 46-68% of DKA presentations and may precede the classic triad of polyuria, polydipsia, and altered mental status [10].

Adrenal insufficiency, both primary (Addison disease) and secondary, causes chronic nausea alongside fatigue, weight loss, and orthostatic hypotension. Morning cortisol levels below 3 mcg/dL are strongly suggestive; an ACTH stimulation test confirms the diagnosis.

Uremia from advanced chronic kidney disease triggers nausea through accumulation of circulating toxins that activate the CTZ. A 2021 study in Kidney International Reports found that GI symptoms, including nausea, were reported by over 50% of patients with eGFR <15 mL/min/1.73 m² [11].

Thyroid dysfunction, particularly hypothyroidism, slows gastric motility and can produce persistent low-grade nausea. TSH screening is warranted in any workup for unexplained chronic nausea.

Central Nervous System Causes

The brain generates nausea through several distinct pathways, and CNS-mediated nausea tends to be more persistent and less responsive to standard antiemetics than peripheral causes.

Migraine is the most common neurological cause. Nausea accompanies 73-95% of migraine attacks according to the International Headache Society classification criteria, and vomiting occurs in roughly half [12]. Triptans and newer CGRP antagonists (rimegepant, ubrogepant) address both headache and associated nausea.

Vestibular disorders produce nausea through mismatch between vestibular, visual, and proprioceptive inputs. Benign paroxysmal positional vertigo (BPPV) is the most common vestibular cause, affecting 2.4% of the general population over a lifetime [13]. The Dix-Hallpike maneuver diagnoses it. The Epley maneuver treats it. Meniere disease, vestibular neuritis, and labyrinthitis are less common but more disabling.

Increased intracranial pressure from mass lesions, hydrocephalus, or idiopathic intracranial hypertension produces a characteristic pattern: nausea and vomiting that is worst in the morning, exacerbated by Valsalva maneuvers, and accompanied by headache and visual changes. This is one of the red-flag presentations that demands urgent neuroimaging.

Cyclic vomiting syndrome (CVS) is an underdiagnosed functional disorder characterized by stereotypical episodes of severe nausea and vomiting lasting hours to days, separated by symptom-free intervals. Adult CVS has an estimated prevalence of 2% and is strongly associated with migraine, cannabis use, and psychological comorbidities [14]. Tricyclic antidepressants (amitriptyline 25-75 mg nightly) are the mainstay of prophylaxis.

When Nausea Signals Something Serious

Most nausea is benign. Some is not. The clinical challenge is pattern recognition.

Seek emergency evaluation for nausea accompanied by any of the following: hematemesis or coffee-ground emesis, severe acute abdominal pain with rigidity, chest pain or diaphoresis, altered mental status or confusion, signs of dehydration with inability to tolerate oral fluids for more than 24 hours, or new severe headache described as "the worst of my life."

Myocardial infarction can present with nausea as the predominant symptom, particularly in women, older adults, and patients with diabetes. The Framingham Heart Study data showed that atypical presentations (including isolated nausea) accounted for nearly a third of MIs in women over 65 [15]. An ECG and troponin should be obtained when nausea co-occurs with diaphoresis, dyspnea, or exertional symptoms.

Acute pancreatitis presents with nausea, vomiting, and epigastric pain radiating to the back. Lipase elevation exceeding three times the upper limit of normal confirms the diagnosis. Gallstones and alcohol account for roughly 80% of cases.

Bowel obstruction and appendicitis are surgical emergencies where nausea is an early and consistent feature. CT abdomen with IV contrast is the imaging modality of choice for both.

Dr. Mark Feldman, editor of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, has stated: "The timing, duration, and associated features of nausea are more diagnostically useful than the nausea itself" [16]. This principle guides the structured approach to workup.

The Diagnostic Workup for Persistent Nausea

When nausea persists beyond 48 to 72 hours without a clear cause, a stepwise evaluation is warranted.

Step 1: History and medication review. Timing matters. Nausea within 30 minutes of eating suggests gastric pathology. Nausea hours after eating points toward gastroparesis or small bowel disease. Morning nausea raises pregnancy, increased intracranial pressure, and uremia as possibilities. A complete medication list, including supplements and over-the-counter drugs, is mandatory.

Step 2: Initial labs. A reasonable panel includes CBC, CMP (electrolytes, creatinine, glucose, liver function), lipase, TSH, and a pregnancy test for individuals of childbearing potential. HbA1c is indicated if diabetes is suspected. Morning cortisol if adrenal insufficiency is in the differential.

Step 3: Imaging. Abdominal X-ray (for obstruction), right upper quadrant ultrasound (for gallbladder disease), or CT abdomen/pelvis depending on clinical suspicion. Dr. Brian Lacy, a gastroenterologist at the Mayo Clinic, recommends that "upper endoscopy should be performed early in patients over 60 or those with alarm features such as weight loss, dysphagia, or iron-deficiency anemia" [17].

Step 4: Motility testing. Gastric emptying scintigraphy is indicated when gastroparesis is suspected. The American Neurogastroenterology and Motility Society consensus recommends a standardized 4-hour egg-based protocol for reliable results [18].

Step 5: Specialist referral. Gastroenterology for refractory GI-related nausea, neurology for suspected CNS causes, endocrinology for metabolic etiologies. Consider psychiatry referral when functional nausea co-occurs with anxiety or somatic symptom disorder.

Evidence-Based Treatment Options

Treatment follows a dual strategy: address the underlying cause and provide symptomatic relief while the workup proceeds.

Dietary modifications are first-line for mild nausea. Small, frequent, bland meals; avoidance of high-fat foods; and staying upright for 30 minutes after eating reduce symptoms in gastroparesis and functional dyspepsia. Ginger (250 mg four times daily) has modest evidence supporting antiemetic efficacy, particularly in pregnancy and postoperative settings [19].

Ondansetron (Zofran) is the most widely prescribed antiemetic. It blocks 5-HT3 receptors in both the CTZ and vagal afferents. The standard dose is 4-8 mg orally or IV every 8 hours. A 2014 Cochrane review found ondansetron effective for postoperative nausea with a number needed to treat of 6 [20]. QTc prolongation is a dose-dependent risk; the FDA issued a safety communication in 2012 limiting single IV doses to 16 mg [21].

Metoclopramide is a prokinetic and central dopamine antagonist. Effective for gastroparesis-related nausea at 5-10 mg before meals, but the FDA mandates a black-box warning for tardive dyskinesia risk with use exceeding 12 weeks [22].

Promethazine provides broad-spectrum antiemetic activity through antihistamine and anticholinergic pathways. Sedation is the primary limitation.

Benzodiazepines (lorazepam 0.5-1 mg) are useful for anticipatory nausea, particularly in chemotherapy settings. They do not address the underlying cause.

For GLP-1-associated nausea specifically, the management algorithm starts with slower dose titration and meal-size reduction. If nausea persists at a given dose, holding that dose for an additional 4 weeks before escalating is recommended by the Endocrine Society 2024 guidelines on pharmacological obesity management [23]. Adding ondansetron 4 mg as needed during titration is common clinical practice.

Acupressure at the P6 (Neiguan) point has some supporting data. A meta-analysis of 40 trials found statistically significant reduction in postoperative nausea compared with sham acupressure, though effect sizes were small [24].

Chronic functional nausea, defined by Rome IV as bothersome nausea occurring at least one day per week for three months without identified cause, may respond to low-dose tricyclic antidepressants or mirtazapine (7.5-15 mg nightly), which has both antiemetic and appetite-stimulating properties [25].

The Role of Hydration and Electrolyte Monitoring

Repeated vomiting accompanying nausea creates secondary problems. Hypokalemia, metabolic alkalosis, and volume depletion compound the original symptom.

Oral rehydration with small, frequent sips of an electrolyte solution is preferred over plain water, which lacks sodium and potassium replacement. The WHO oral rehydration solution formula (75 mEq/L sodium, 75 mmol/L glucose) remains the global standard [26]. Commercial products like Pedialyte approximate this composition.

IV fluid resuscitation with normal saline or lactated Ringer's is indicated when oral intake fails. Potassium supplementation should be guided by serum levels, not empiric dosing, since both hypokalemia and hyperkalemia carry cardiac risk.

Patients on GLP-1 receptor agonists who develop persistent vomiting need prompt evaluation for rare but serious complications including pancreatitis (lipase measurement) and, in patients with type 2 diabetes, euglycemic DKA (serum ketones and blood gas).

For patients experiencing medication-related nausea lasting more than two weeks despite dose adjustment, switching to an alternative agent within the same class (or a different class) typically resolves symptoms within 5 to 10 days.